US Patent Issued to CHRISTALFARMA on April 29 for "Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization" (Italian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,035, issued on April 29, was assigned to CHRISTALFARMA S.R.L. (Milan).

"Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization" was invented by Maria Cristina Del Bono (Milan) and Francesco Bonomo (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Oral tablet comprising as active principle an association of dry extracts of turmeric, pomegranate and Boswellia, with colonic release, wherein said release is guaranteed by the presence of a combination of sodium alginate and hydroxypropyl methylcellulose in ...